Prevalence of Barrett’s esophagus in obese patients undergoing pre-bariatric surgery evaluation: a systematic review and meta-analysis

Abstract

Introduction Obesity is a known risk factor for gastroesophageal reflux disease (GERD), Barrett’s esophagus (BE), and esophageal adenocarcinoma (EAC). Obese patients routinely undergo preoperative esophagogastroduodenoscopy (EGD) before bariatric procedures. We aimed to assess the prevalence of BE in this patient population.

Methods We conducted a comprehensive literature search ending in March 2019. Search results were imported into covidence.org and screened by two independent reviewers. Heterogeneity was assessed using I ² and Q statistics and publication bias using funnel plots and the Orwin fail-safe test. Random-effects modeling was used in all analyses.

Results Of 4087 citations, 77 were reviewed in full text and 29 were included in the final analysis based on our predetermined inclusion/exclusion criteria. A total of 13 434 patients underwent pre-bariatric surgery EGD. The pooled prevalence of BE using random-effects modeling was 0.9 % (95 % confidence interval [CI] 0.7 % – 1.3 %); P < 0.001; I ² = 58 %, Q = 67). In meta-regression analyses, controlling for sex and GERD, we found a positive association between mean body mass index (BMI) and the prevalence of BE (β = 0.15 [95 %CI 0.02 – 0.28]; P = 0.03). A linear relationship between the prevalence of BE and the prevalence of GERD was also noted (β = 3.9 [95 %CI 0.4 – 7.5]; P = 0.03).

Conclusions Obesity has been postulated as a major risk factor for BE, yet we found that the prevalence of BE in morbidly obese patients undergoing preoperative EGD was very low. Therefore, obesity alone may not be a major risk factor for BE.

Publication History

Received: 30 October 2019

Accepted: 19 February 2020

Article published online:
23 April 2020

• References

• 1 Shaheen NJ, Richter JE. Barrett's oesophagus. Lancet 2009; 373: 850-861
• 2 Kuipers EJ, Spaander MC. Natural history of Barrett's esophagus. Dig Dis Sci 2018; 63: 1997-2004
• 3 Qumseya BJ, Wani S, Gendy S. et al. Disease progression in Barrett's low-grade dysplasia with radiofrequency ablation compared with surveillance: systematic review and meta-analysis. Am J Gastroenterol 2017; 112: 849-865
• 4 Rastogi A, Puli S, El-Serag HB. et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 2008; 67: 394-398
• 5 Thrift AP, Whiteman DC. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol 2012; 23: 3155-3162
• 6 Hayeck TJ, Kong CY, Spechler SJ. et al. The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus 2010; 23: 451-457
• 7 Qumseya B, Sultan S. ASGE Standards of Practice Committee. et al. ASGE guideline on screening and surveillance of Barrett's esophagus. Gastrointest Endosc 2019; 90: 335-359 e332
• 8 Qumseya BJ, Bukannan A, Gendy S. et al. Systematic review and meta-analysis of prevalence and risk factors for Barrett's esophagus. Gastrointest Endosc 2019;
• 9 Chandar AK, Iyer PG. Role of obesity in the pathogenesis and progression of Barrett's esophagus. Gastroenterol Clin North Am 2015; 44: 249-264
• 10 Chen CC, Hsu YC, Lee CT. et al. Central obesity and H. pylori infection influence risk of Barrett's esophagus in an Asian population. PLoS One 2016; 11: e0167815
• 11 El-Serag HB, Kvapil P, Hacken-Bitar J. et al. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol 2005; 100: 2151-2156
• 12 Pabla M, Singh J, Malani AK. et al. Barrett's esophagus and obesity. Am J Gastroenterol 2007; 102: 204-205; author reply 205
• 13 Palmer MK, Toth PP. Trends in lipids, obesity, metabolic syndrome, and diabetes mellitus in the United States: An NHANES analysis (2003–2004 to 2013–2014). Obesity (Silver Spring) 2019; 27: 309-314
• 14 Gomes DCK, Sichieri R, Junior EV. et al. Trends in obesity prevalence among Brazilian adults from 2002 to 2013 by educational level. BMC Public Health 2019; 19: 965
• 15 Hatthachote P, Rangsin R, Mungthin M. et al. Trends in the prevalence of obesity among young Thai men and associated factors: from 2009 to 2016. Mil Med Res 2019; 6: 13
• 16 Alnohair S. Obesity in Gulf countries. Int J Health Sci (Qassim) 2014; 8: 79-83
• 17 Badran M, Laher I. Obesity in Arabic-speaking countries. J Obes 2011; 2011: 686430
• 18 Pengpid S, Peltzer K. Prevalence and correlates of underweight and overweight/obesity among women in India: results from the National Family Health Survey 2015–2016. Diabetes Metab Syndr Obes 2019; 12: 647-653
• 19 Wang Y, Xue H, Sun M. et al. Prevention and control of obesity in China. Lancet Glob Health 2019; 7: e1166-e1167
• 20 Evans JA, Muthusamy VR. American Society for Gastrointestinal Endoscopy Standards of Practice Committee, . et al. The role of endoscopy in the bariatric surgery patient. Gastrointest Endosc 2015; 81: 1063-1072
• 21 Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377-384
• 22 de Moura Almeida A, Cotrim HP, Santos AS. et al. Preoperative upper gastrointestinal endoscopy in obese patients undergoing bariatric surgery: is it necessary?. Surg Obes Relat Dis 2008; 4: 144-149
• 23 Azagury D, Dumonceau JM, Morel P. et al. Preoperative work-up in asymptomatic patients undergoing Roux-en-Y gastric bypass: is endoscopy mandatory?. Obes Surg 2006; 16: 1304-1311
• 24 D'Hondt M, Steverlynck M, Pottel H. et al. Value of preoperative esophagogastroduodenoscopy in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass. Acta Chir Belg 2013; 113: 249-253
• 25 Dietz J, Ulbrich-Kulcynski JM, Souto KEP. et al. Prevalence of upper digestive endoscopy and gastric histopathology findings in morbidly obese patients. Arq Gastroenterol 2012; 49: 52-55
• 26 D'Silva M, Bhasker AG, Kantharia NS. et al. High-percentage pathological findings in obese patients suggest that esophago-gastro-duodenoscopy should be made mandatory prior to bariatric surgery. Obes Surg 2018; 28: 2753-2759
• 27 Dutta SK, Arora M, Kireet A. et al. Upper gastrointestinal symptoms and associated disorders in morbidly obese patients: a prospective study. Dig Dis Sci 2009; 54: 1243-1246
• 28 Endo Y, Ohta M, Tada K. et al. Clinical significance of upper gastrointestinal endoscopy before laparoscopic bariatric procedures in Japanese patients. Surg Today 2019; 49: 27-31
• 29 Estevez-Fernandez S, Sanchez-Santos R, Marino-Padin E. et al. Esophagogastric pathology in morbid obese patient: Preoperative diagnosis, influence in the selection of surgical technique. Rev Esp Enferm Dig 2015; 107: 408-412
• 30 Fernandes SR, Meireles LC, Carrilho-Ribeiro L. et al. The role of routine upper gastrointestinal endoscopy before bariatric surgery. Obes Surg 2016; 26: 2105-2110
• 31 Gorodner V, Buxhoeveden R, Clemente G. et al. Barrett's esophagus after Roux-en-Y gastric bypass: does regression occur?. Surg Endosc 2017; 31: 1849-1854
• 32 Hutopila I, Constantin A, Copaescu C. Gastroesophageal reflux before metabolic surgery. Chirurgia (Bucur) 2018; 113: 101-107
• 33 Kuper MA, Kratt T, Kramer KM. et al. Effort, safety, and findings of routine preoperative endoscopic evaluation of morbidly obese patients undergoing bariatric surgery. Surg Endosc 2010; 24: 1996-2001
• 34 Loewen M, Giovanni J, Barba C. Screening endoscopy before bariatric surgery: a series of 448 patients. Surg Obes Relat Dis 2008; 4: 709-712
• 35 Madan AK, Speck KE, Hiler ML. Routine preoperative upper endoscopy for laparoscopic gastric bypass: is it necessary?. Am Surg 2004; 70: 684-686
• 36 Mihmanli M, Yazici P, Isil G. et al. Should we perform preoperative endoscopy routinely in obese patients undergoing bariatric surgery?. Bariatr Surg Pract Patient Care 2016; 11: 73-77
• 37 Mong C, Van Dam J, Morton J. et al. Preoperative endoscopic screening for laparoscopic Roux-en-Y gastric bypass has a low yield for anatomic findings. Obes Surg 2008; 18: 1067-1073
• 38 Munoz R, Ibanez L, Salinas J. et al. Importance of routine preoperative upper GI endoscopy: why all patients should be evaluated?. Obes Surg 2009; 19: 427-431
• 39 Praveenraj P, Gomes RM, Kumar S. et al. Diagnostic yield and clinical implications of preoperative upper gastrointestinal endoscopy in morbidly obese patients undergoing bariatric surgery. J Laparoendosc Adv Surg Tech A 2015; 25: 465-469
• 40 Schigt A, Coblijn U, Lagarde S. et al. Is esophagogastroduodenoscopy before Roux-en-Y gastric bypass or sleeve gastrectomy mandatory?. Surg Obes Relat Dis 2014; 10: 411-417; quiz 565
• 41 Schneider R, Lazaridis I, Kraljevic M. et al. The impact of preoperative investigations on the management of bariatric patients; results of a cohort of more than 1200 cases. Surg Obes Relat Dis 2018; 14: 693-699
• 42 Sun W, Dang JT, Switzer NJ. et al. The utility of routine esophagogastroduodenoscopy prior to laparoscopic Roux-En-Y gastric bypass. Surg Endosc 2017; 31: S271
• 43 Wolter S, Dupree A, Miro J. et al. Upper gastrointestinal endoscopy prior to bariatric surgery-mandatory or expendable? An analysis of 801 cases. Obesity Surg 2017; 27: 1938-1943
• 44 Zeni TM, Frantzides CT, Mahr C. et al. Value of preoperative upper endoscopy in patients undergoing laparoscopic gastric bypass. Obes Surg 2006; 16: 142-146
• 45 Sharaf RN, Weinshel EH, Bini EJ. et al. Endoscopy plays an important preoperative role in bariatric surgery. Obes Surg 2004; 14: 1367-1372
• 46 Lee J, Wong SK, Liu SY. et al. Is preoperative upper gastrointestinal endoscopy in obese patients undergoing bariatric surgery mandatory? An Asian perspective. Obes Surg 2017; 27: 44-50
• 47 Csendes A, Burgos AM, Smok G. et al. Effect of gastric bypass on Barrett's esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg 2006; 10: 259-264
• 48 Santo MA, Quintanilha SR, Mietti CA. et al. Endoscopic changes related to gastroesophageal reflux disease: comparative study among bariatric surgery patients. Arq Bras Cir Dig 2015; 28 (Suppl. 01) 36-38
• 49 Masci E, Viaggi P, Mangiavillano B. et al. No increase in prevalence of Barrett's oesophagus in a surgical series of obese patients referred for laparoscopic gastric banding. Dig Liver Dis 2011; 43: 613-615
• 50 Wong HM, Yang W, Yang J. et al. The value of routine gastroscopy before laparoscopic Roux-en-Y gastric bypass surgery in Chinese patients. Surg Obes Relat Dis 2015; 11: 303-307
• 51 Schirmer B, Erenoglu C, Miller A. Flexible endoscopy in the management of patients undergoing Roux-en-Y gastric bypass. Obes Surg 2002; 12: 634-638
• 52 Bueter M, Thalheimer A, le Roux CW. et al. Upper gastrointestinal investigations before gastric banding. Surg Endosc 2010; 24: 1025-1030
• 53 Peromaa-Haavisto P, Victorzon M. Is routine preoperative upper GI endoscopy needed prior to gastric bypass?. Obes Surg 2013; 23: 736-739
• 54 Salama A, Saafan T, El AnsariW. et al. Is routine preoperative esophagogastroduodenoscopy screening necessary prior to laparoscopic sleeve gastrectomy? Review of 1555 cases and comparison with current literature. Obes Surg 2018; 28: 52-60
• 55 Gomez V, Bhalla R, Heckman MG. et al. Routine screening endoscopy before bariatric surgery: is it necessary?. Bariatr Surg Pract Patient Care 2014; 9: 143-149
• 56 Renehan AG, Tyson M, Egger M. et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578
• 57 Garcia JM, Splenser AE, Kramer J. et al. Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study. Clin Gastroenterol Hepatol 2014; 12: 229-238 e223
• 58 Ramos-Nino ME. The role of chronic inflammation in obesity-associated cancers. ISRN Oncol 2013; 2013: 697521
• 59 Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005; 143: 199-211
• 60 Jacobson BC, Chan AT, Giovannucci EL. et al. Body mass index and Barrett's oesophagus in women. Gut 2009; 58: 1460-1466
• 61 Singh S, Sharma AN, Murad MH. et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013; 11: 1399-1412 e1397
• 62 Krishnamoorthi R, Singh S, Ragunathan K. et al. Factors associated with progression of Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2018; 16: 1046-1055 e1048
• 63 Qumseya B, Gendy S, Wallace A. Gastroesophageal reflux disease and Barrett’s esophagus post sleeve gastrectomy: a cause of concern for the future of endoscopic bariatric procedures (a systematic review and meta-analysis). Gastrointestinal Endoscopy 2019; 89: AB187-AB188